Search Results

Your search for Phillip J. Gray, MD,Phillip J. Gray, MD matches 2 pages

Showing 1 - 2

By Alice Goodman / December 15, 2012

Early Quality of Life Better with Proton-beam Therapy, but Late Effects Similar to Other Treatment Modalities for Prostate Cancer

Differing patterns of patient-reported quality of life for three-dimensional (3D) conformal radiotherapy, intensity-modulated radiation therapy, and proton-beam therapy were reported in a nonrandomized comparison of three modern cohorts of patients with prostate cancer. The study was presented at...

By Phillip J. Gray, MD / October 15, 2014

Determining Androgen-Deprivation Therapy

Determining an appropriate course of androgen-deprivation therapy in patients with prostate cancer is complex. For patients with high-risk features, 4 to 6 months of androgen-deprivation therapy helps, but 28 to 36 months is better in terms of disease control and overall survival. In the study by...

Nov

Today In Oncology

Search Results

Your search for Phillip J. Gray, MD,Phillip J. Gray, MD matches 2 pages

Early Quality of Life Better with Proton-beam Therapy, but Late Effects Similar to Other Treatment Modalities for Prostate Cancer

Determining Androgen-Deprivation Therapy

What Is the Impact of a Colon or Colorectal Cancer Diagnosis on Younger Adults?

International Cancer Organizations Present Collaborative Work During Oncology Event in China

Is There a Role for Neoadjuvant Chemotherapy in HR-Positive, HER2-Negative Early Breast Cancer?

Suicide-Related Mortality in Male AYA Cancer Survivors

Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC